-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Replimune Group, Raises Price Target to $9

Benzinga·06/30/2026 12:51:07
Listen to the news
Wedbush analyst Robert Driscoll maintains Replimune Group (NASDAQ:REPL) with a Neutral and raises the price target from $6 to $9.